DVBCWPW1 ;ALB/CMM PULMONARY TB AND MYCO. DIS. WKS TEXT - 1 ; 6 MARCH 1997
;;2.7;AMIE;**12**;Apr 10, 1995
;
;
TXT ;
;;A. Review of Medical Records:
;;
;;
;;
;;B. Medical History (Subjective Complaints):
;;
;; Comment on:
;; 1. Activity of pulmonary tuberculosis or other mycobacterial disease.
;;
;;
;; 2. Date of inactivity if it is not active.
;;
;;
;; 3. Identity of organism (if possible).
;;
;;
;;C. Physical examination (Objective Findings):
;;
;; Address each of the following and fully describe current findings:
;; 1. Extent of structural damage to lungs.
;;
;;
;; 2. If patient was hospitalized for 6 months or more, what is the
;; condition at the end of hospitalization?
;;
;;
;; 3. If patient was hospitalized for 12 months or more, what is the
;; condition at the end of hospitalization?
;;
;;
;;D. Diagnostic and Clinical Tests:
;;
;; Provide:
;; Pulmonary Function Tests, if indicated. When the results of
;; pre-bronchodilator pulmonary function tests are NORMAL, post-
;; bronchodilator studies are not required for VA evaluation purposes.
;; IN ALL OTHER CASES, post-bronchodilator studies shuld be conducted
;; unless contraindicated (because of allergy to medication, etc.) or
;; if the veteran was on bronchodilators before the test and had taken
;; his or her medication within a few hours of the study. An examiner
;; who determines that a post-bronchodilator study should not be
;; performed should provide an explanation of why not. If there is
;; a disparity between the results of different pulmonary function
;; tests (FEV-1, FVC, etc.), the examiner should indicate which test
;; result is the best indicator of the veteran's level of pulmonary
;; functioning.
;;
;;
;;E. Diagnosis:
;;
;; In reactivated cases, is this reactivation of the old disease or a
;; separate and distinct new infection.
;;
;;
;;
;;ADDITIONAL NOTE TO THE PHYSICIAN:
;;In all claims, if the disease is inactive and if the inactivity was
;;confirmed at a non-VA facility, obtain the name and mailing address of
;;the facility from the veteran so that the Regional Office may request
;;the report.
;;
;;
;;Signature: Date:
;;END
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HDVBCWPW1 2406 printed Dec 13, 2024@01:53:40 Page 2
DVBCWPW1 ;ALB/CMM PULMONARY TB AND MYCO. DIS. WKS TEXT - 1 ; 6 MARCH 1997
+1 ;;2.7;AMIE;**12**;Apr 10, 1995
+2 ;
+3 ;
TXT ;
+1 ;;A. Review of Medical Records:
+2 ;;
+3 ;;
+4 ;;
+5 ;;B. Medical History (Subjective Complaints):
+6 ;;
+7 ;; Comment on:
+8 ;; 1. Activity of pulmonary tuberculosis or other mycobacterial disease.
+9 ;;
+10 ;;
+11 ;; 2. Date of inactivity if it is not active.
+12 ;;
+13 ;;
+14 ;; 3. Identity of organism (if possible).
+15 ;;
+16 ;;
+17 ;;C. Physical examination (Objective Findings):
+18 ;;
+19 ;; Address each of the following and fully describe current findings:
+20 ;; 1. Extent of structural damage to lungs.
+21 ;;
+22 ;;
+23 ;; 2. If patient was hospitalized for 6 months or more, what is the
+24 ;; condition at the end of hospitalization?
+25 ;;
+26 ;;
+27 ;; 3. If patient was hospitalized for 12 months or more, what is the
+28 ;; condition at the end of hospitalization?
+29 ;;
+30 ;;
+31 ;;D. Diagnostic and Clinical Tests:
+32 ;;
+33 ;; Provide:
+34 ;; Pulmonary Function Tests, if indicated. When the results of
+35 ;; pre-bronchodilator pulmonary function tests are NORMAL, post-
+36 ;; bronchodilator studies are not required for VA evaluation purposes.
+37 ;; IN ALL OTHER CASES, post-bronchodilator studies shuld be conducted
+38 ;; unless contraindicated (because of allergy to medication, etc.) or
+39 ;; if the veteran was on bronchodilators before the test and had taken
+40 ;; his or her medication within a few hours of the study. An examiner
+41 ;; who determines that a post-bronchodilator study should not be
+42 ;; performed should provide an explanation of why not. If there is
+43 ;; a disparity between the results of different pulmonary function
+44 ;; tests (FEV-1, FVC, etc.), the examiner should indicate which test
+45 ;; result is the best indicator of the veteran's level of pulmonary
+46 ;; functioning.
+47 ;;
+48 ;;
+49 ;;E. Diagnosis:
+50 ;;
+51 ;; In reactivated cases, is this reactivation of the old disease or a
+52 ;; separate and distinct new infection.
+53 ;;
+54 ;;
+55 ;;
+56 ;;ADDITIONAL NOTE TO THE PHYSICIAN:
+57 ;;In all claims, if the disease is inactive and if the inactivity was
+58 ;;confirmed at a non-VA facility, obtain the name and mailing address of
+59 ;;the facility from the veteran so that the Regional Office may request
+60 ;;the report.
+61 ;;
+62 ;;
+63 ;;Signature: Date:
+64 ;;END
